What are the most common side effects of AZTREONAM?

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for AZTREONAM. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Is AZTREONAM the same as Aztreonam?

Aztreonam is a brand name for AZTREONAM. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

AZTREONAM

Q: What is AZTREONAM used for?

AZTREONAM (brand name Aztreonam) is a Other indicated for INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of aztreonam for injection, USP and other antibacterial drugs, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data.

Q: How does AZTREONAM work?

AZTREONAM works through the following mechanism: Mechanism of Action Aztreonam is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Aztreonam has activity in the presence of some beta-lactamases, both penicillinases and cephalosporinases, of Gram-negative and Gram-positive bacteria..

Other

Brand names: Aztreonam

Intramuscular, Intravenous

Mechanism of Action

Mechanism of Action Aztreonam is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Aztreonam has activity in the presence of some beta-lactamases, both penicillinases and cephalosporinases, of Gram-negative and Gram-positive bacteria.

Indications

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of aztreonam for injection

USP and other antibacterial drugs

they should be considered in selecting or modifying antibacterial therapy. In the absence of such data

including pyelonephritis and cystitis (initial and recurrent) caused by Escherichia coli

Klebsiella pneumoniae

Proteus mirabilis

Contraindications

• CONTRAINDICATIONS This preparation is contraindicated in patients with known hypersensitivity to aztreonam or any other component in the formulation.

FDA Warnings

WARNINGS Both animal and human data suggest that aztreonam for injection, USP is rarely cross-reactive with other beta-lactam antibiotics and weakly immunogenic
Serious hypersensitivity reactions may require epinephrine and other emergency measures
) Clostridium difficile- associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including aztreonam for injection, and may range in severity from mild diarrhea to fatal colitis
Rare cases of toxic epidermal necrolysis have been reported in association with aztreonam in patients undergoing bone marrow transplant with multiple risk factors including sepsis, radiation therapy, and other concomitantly administered drugs associated with toxic epidermal necrolysis

Known Side Effects

6 documented side effects by frequency

Shortness of Breath

1-10%

Cough

1-10%

Fever

1-10%

Condition Worsened

0.1-1%

Rash

0.1-1%

Drug Not Working

0.1-1%

Community Discussions

No community discussions found for AZTREONAM yet.

Primary sources

Every figure on this page links back to its primary source. See data sources for full provenance.

DailyMed FDA label search → AZTREONAM openFDA label JSON → AZTREONAM FAERS adverse-event reports → AZTREONAM ClinicalTrials.gov → completed Phase 2+ trials of AZTREONAM

Compare With

0 available comparisons

No comparisons yet.

Formulations

Dosage Forms

Tablet

Route

Intramuscular, Intravenous